Drug-Device Combination Market Worth US $18.54 Billion by 2014
Market of Drug-device combination is expected to be worth US $18.54 billion by 2014
Wilmington, DE, August 07, 2009 --(PR.com)-- According to a new market research report, ‘Drug-Device Combination Market (2009 - 2014)’, published by MarketsandMarkets (www.marketsandmarkets.com), the total drug-device combination market is expected to be worth US$18.54 billion by 2014, out of which the U.S. market will account for nearly 30.9% of the total revenues. The global market is expected to record a CAGR of 11.8% from 2009 to 2014.
Browse 144 market data tables and in-depth TOC on drug-device market.
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/drug-and-device-combination-101.html
The drug-device combination market includes all the products that are a combination of drugs and devices and can be chemically or physically united or co-packaged as separate, cross labeled products. The market is driven by the growing demand for treating only the; targeted area, increasing incidences of infections associated with regular medical devices, need for faster healing, and overall reduced cost of treatment and accelerated approval process of the drug-device combination products.
The drug eluting stents (DES) market is the largest segment and is expected to reach US $8.47 billion by 2014 at a CAGR of 9.3%. The antimicrobial catheter market is estimated to grow to a size of US $1.23 billion in 2014 which presents the highest growth potential with an expected growth rate of 23.4% in 2014. The cardiovascular treatment market is estimated to record revenues of US $9.59 billion in 2014 on account of the fact that cardiovascular diseases are one of the primary causes of death globally.
The European market is the largest geographical segment; and is expected to be worth US $7.25 billion by 2014. Its 11.2% CAGR for 2009 to 2014 is driven by the growing aging population and the improvements in medical science and biotechnology that enables new product development. The second largest segment is the U.S. with a CAGR of 8.7% for 2009 to 2014. It is expected to reach US $5.73 billion by 2014.
The report is titled ‘Drug-Device Combination Market (2009-2014) and was published in July 2009.
Scope of the Report
This report aims to identify the specific segments that offer the highest growth potential in the near future; compares the products in respect to the relative entry barriers and expected new product developments in those segments. The report discusses the segmentation of the global drug-device combination as follows:
1. Drug device combination – products
Antimicrobial catheter, advanced wound care products, bone graft substitutes, antibiotic bone cements, drug eluting stents, photodynamic therapy, closed loop glucose monitor and insulin pump, steroid eluting electrodes and others.
2. Drug device combination – application
Bone treatment, cancer treatment, diabetes treatment, skin care treatment, antimicrobial applications, urological treatment, non cardiovascular treatment, cardiovascular treatment, ophthalmic treatment, others.
3. Drug device combination – technology
Bone graft substitutes- synthetic bone graft substitutes, demineralised bone matrix and bone morphogenic proteins.
Contact their representative to sponsor this report.
About MarketsandMarkets
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.
Contact:
Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
###
Browse 144 market data tables and in-depth TOC on drug-device market.
Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/drug-and-device-combination-101.html
The drug-device combination market includes all the products that are a combination of drugs and devices and can be chemically or physically united or co-packaged as separate, cross labeled products. The market is driven by the growing demand for treating only the; targeted area, increasing incidences of infections associated with regular medical devices, need for faster healing, and overall reduced cost of treatment and accelerated approval process of the drug-device combination products.
The drug eluting stents (DES) market is the largest segment and is expected to reach US $8.47 billion by 2014 at a CAGR of 9.3%. The antimicrobial catheter market is estimated to grow to a size of US $1.23 billion in 2014 which presents the highest growth potential with an expected growth rate of 23.4% in 2014. The cardiovascular treatment market is estimated to record revenues of US $9.59 billion in 2014 on account of the fact that cardiovascular diseases are one of the primary causes of death globally.
The European market is the largest geographical segment; and is expected to be worth US $7.25 billion by 2014. Its 11.2% CAGR for 2009 to 2014 is driven by the growing aging population and the improvements in medical science and biotechnology that enables new product development. The second largest segment is the U.S. with a CAGR of 8.7% for 2009 to 2014. It is expected to reach US $5.73 billion by 2014.
The report is titled ‘Drug-Device Combination Market (2009-2014) and was published in July 2009.
Scope of the Report
This report aims to identify the specific segments that offer the highest growth potential in the near future; compares the products in respect to the relative entry barriers and expected new product developments in those segments. The report discusses the segmentation of the global drug-device combination as follows:
1. Drug device combination – products
Antimicrobial catheter, advanced wound care products, bone graft substitutes, antibiotic bone cements, drug eluting stents, photodynamic therapy, closed loop glucose monitor and insulin pump, steroid eluting electrodes and others.
2. Drug device combination – application
Bone treatment, cancer treatment, diabetes treatment, skin care treatment, antimicrobial applications, urological treatment, non cardiovascular treatment, cardiovascular treatment, ophthalmic treatment, others.
3. Drug device combination – technology
Bone graft substitutes- synthetic bone graft substitutes, demineralised bone matrix and bone morphogenic proteins.
Contact their representative to sponsor this report.
About MarketsandMarkets
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.
Contact:
Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com
###
Contact
MarketsandMarkets: Market Research Reports
Sunita Christ
888-989-8004
http://www.marketsandmarkets.com/
Sunita Christ
888-989-8004
http://www.marketsandmarkets.com/
Contact
Categories